Increased serum levels of IP-10 have been reported to return to baseline during and after TB therapy [10,13,16–18] and monitoring IP-10 after starting treatment or post treatment may be clinically informative [19] to predict cure or detect relapse [20]. This evidence concerns the gene CXCL10 and tuberculosis.